Introduction Finding the risk factors for thromboembolic (TE) disease and preventing its development in pregnant women is important. Asthma a common chronic women. The aim of study to find factors. Material methods From 2004 2011, 55,057 were recruited from Taiwan database. They grouped into AS non-AS groups. subjects divided three Group 1: with before pregnancy or during pregnancy; without aft...

PURPOSE OF REVIEW Although early acute traumatic coagulopathy has received much recent attention, the procoagulopathy that often follows appears less appreciated. Thromboembolic disease following trauma is common and lethal, but very effective prophylactic strategies are available. These strategies are variably implemented because of the difficulty in quantifying the magnitude of procoagulopath...

The actuarial survival and thromboembolic rates for the three types of cloth-covered Starr-Edwards mitral prostheses, models 6300, 6310/6320, and 6400 followed 6, 5, and 2 years, respectively, were not significantly different throughout the years they were followed. The combined cumulative survival and thromboembolic proportion at 5 years for these prostheses were 71 and 66 per cent, respective...

Spontaneous acute superficial vein thrombosis (SVT) of the leg is now generally recognized as an integral component of venous thromboembolic disease with potentially severe consequences. However, the relatively low grades of some current international recommendations and uncertainty regarding the cost-effectiveness of available therapies may prompt questioning of the real need to treat patients...

O ur understanding of chronic thromboembolic pulmonary hypertension (CTEPH), in terms of its natural history, pathophysiology and management of patients, has greatly improved since the landmark descriptions given by Kenneth Moser and Nina Braunwald [1] more than 40 yrs ago. At that time, small case series were available depicting the clinical features of patients suffering from ‘‘long-standing ...

Immunomodulating agents such as thalidomide and its newly emerged derivative, lenalidomide, are becoming increasingly popular in the treatment of multiple myeloma because of their ability to combat drug resistance. Clinical trials suggest that thalidomide and lenalidomide are effective in all stages of multiple myeloma treatment-new diagnoses, stem cell transplantations, maintenance therapy, an...

Venous thrombosis is a common disease process leading to tens of thousands of deaths per year. Despite prophylactic efforts, venous thromboembolic disease is a common and serious complication in critical care patients. Difficulty and delay in obtaining diagnostic imaging studies to rule out deep venous thrombosis is exacerbated by increased susceptibility that critically ill patients have to th...